Symbol renamed to Coherent Corp (NASDAQ:COHR) in Oct 2022
IIVI - II-VI Incorporated
NASDAQ
->
Technology
->
Scientific & Technical Instruments
Saxonburg,
United States
Type: Equity
IIVI price evolution
IIVI
| (in millions $) | 30 Oct 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2582.37 | $2600.32 | $2649.72 | |
| Short term investments | ||||
| Net receivables | $700.33 | $653.1 | $604.21 | |
| Inventory | $902.56 | $879.51 | $819.09 | |
| Total current assets | $4305.19 | $4233.8 | $4165.8 | |
| Long term investments | $29 | |||
| Property, plant & equipment | $1363.19 | $1320.19 | $1272.38 | |
| Goodwill & intangible assets | $1921.16 | $1950.24 | $1969.63 | |
| Total noncurrent assets | $3539.65 | $3533.4 | $3483.49 | |
| Total investments | ||||
| Total assets | $7844.85 | $7767.2 | $7649.28 | |
| Current liabilities | ||||
| Accounts payable | $434.92 | $361.53 | $339.99 | |
| Deferred revenue | ||||
| Short long term debt | $430.79 | $1412.01 | $1406.13 | |
| Total current liabilities | $1266.96 | $2123.88 | $2083.24 | |
| Long term debt | $2007.43 | $1043.97 | $1063.03 | |
| Total noncurrent liabilities | $2194.61 | $1259.14 | $1282.47 | |
| Total debt | $2438.21 | $2455.98 | $2469.16 | |
| Total liabilities | $3461.57 | $3383.02 | $3365.71 | |
| Shareholders' equity | ||||
| Retained earnings | $1348.13 | $1321.78 | $1289.92 | |
| Other shareholder equity | -$2.17 | $48.12 | $15.07 | |
| Total shareholder equity | $3616.47 | $3627.76 | $3537.41 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2582.37 | $1591.89 | $493.05 | $204.87 |
| Short term investments | ||||
| Net receivables | $700.33 | $658.96 | $598.12 | $269.64 |
| Inventory | $902.56 | $695.83 | $619.81 | $296.28 |
| Total current assets | $4305.19 | $3027.39 | $1788.97 | $812.91 |
| Long term investments | $73.77 | $76.21 | ||
| Property, plant & equipment | $1363.19 | $1242.91 | $1214.77 | $582.79 |
| Goodwill & intangible assets | $1921.16 | $2015.19 | $1997.38 | $459.1 |
| Total noncurrent assets | $3539.65 | $3485.26 | $3445.74 | $1140.86 |
| Total investments | $73.77 | $76.21 | ||
| Total assets | $7844.85 | $6512.65 | $5234.71 | $1953.77 |
| Current liabilities | ||||
| Accounts payable | $434.92 | $294.49 | $268.77 | $104.46 |
| Deferred revenue | ||||
| Short long term debt | $430.79 | $87.41 | $93.88 | $23.83 |
| Total current liabilities | $1266.96 | $729.59 | $672.89 | $270.56 |
| Long term debt | $2007.43 | $1438.63 | $2280.79 | $443.16 |
| Total noncurrent liabilities | $2194.61 | $1650.71 | $2485.02 | $550 |
| Total debt | $2438.21 | $1526.04 | $2374.68 | $467 |
| Total liabilities | $3461.57 | $2380.3 | $3157.91 | $820.56 |
| Shareholders' equity | ||||
| Retained earnings | $1348.13 | $1136.78 | $876.55 | $943.58 |
| Other shareholder equity | -$2.17 | $14.27 | -$87.38 | -$24.22 |
| Total shareholder equity | $3616.47 | $3406.17 | $2076.8 | $1133.21 |
| (in millions $) | 30 Oct 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $886.96 | $827.72 | $806.82 | |
| Cost of revenue | $570.5 | $506.05 | $495.65 | |
| Gross Profit | $316.47 | $321.67 | $311.17 | |
| Operating activities | ||||
| Research & development | $95.92 | $96.89 | $95.33 | |
| Selling, general & administrative | $106.3 | $118.01 | $117.62 | |
| Total operating expenses | $218.98 | $215.15 | $214.75 | |
| Operating income | $97.48 | $106.53 | $96.42 | |
| Income from continuing operations | ||||
| EBIT | $97.48 | $106.53 | $96.42 | |
| Income tax expense | $5.35 | $14.03 | $11.7 | |
| Interest expense | $48.5 | $43.5 | $17.06 | |
| Net income | ||||
| Net income | $43.64 | $49 | $67.66 | |
| Income (for common shares) | $26.34 | $31.85 | $50.95 | |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3316.62 | $3105.89 | $2380.07 | $1362.5 |
| Cost of revenue | $2051.12 | $1889.68 | $1560.52 | $841.15 |
| Gross Profit | $1265.5 | $1216.21 | $819.55 | $521.35 |
| Operating activities | ||||
| Research & development | $377.11 | $330.11 | $339.07 | $139.16 |
| Selling, general & administrative | $474.1 | $483.99 | $441 | $233.52 |
| Total operating expenses | $862.43 | $803.72 | $794.07 | $370.12 |
| Operating income | $403.06 | $412.49 | $25.48 | $151.23 |
| Income from continuing operations | ||||
| EBIT | $403.06 | $412.49 | $25.48 | $151.23 |
| Income tax expense | $47.05 | $55.04 | $3.1 | $21.3 |
| Interest expense | $121.25 | $59.9 | $89.41 | $22.42 |
| Net income | ||||
| Net income | $234.76 | $297.55 | -$67.03 | $107.52 |
| Income (for common shares) | $166.53 | $260.32 | -$67.03 | $107.52 |
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Net income | $43.64 | $49 | $67.66 | $74.46 |
| Operating activities | ||||
| Depreciation | $73.25 | $72.81 | $71.03 | $69.69 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $15.79 | $16.71 | $16.91 | $23.8 |
| Total cash flows from operations | $137.32 | $35.92 | $187.75 | $52.34 |
| Investing activities | ||||
| Capital expenditures | -$118.34 | -$94.3 | -$54.12 | -$47.56 |
| Investments | ||||
| Total cash flows from investing | -$118.34 | -$100.05 | -$54.12 | -$47.56 |
| Financing activities | ||||
| Dividends paid | -$6.9 | -$6.9 | -$6.9 | -$13.81 |
| Sale and purchase of stock | $0.68 | $8.81 | $0.89 | $7.48 |
| Net borrowings | -$15.51 | -$20.07 | $953.96 | -$15.51 |
| Total cash flows from financing | -$28.33 | -$19.59 | $946.84 | -$35.97 |
| Effect of exchange rate | -$8.6 | $34.32 | $9.08 | -$0.52 |
| Change in cash and equivalents | -$17.94 | -$49.4 | $1089.54 | -$31.72 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | $234.76 | $297.55 | -$67.03 | $107.52 |
| Operating activities | ||||
| Depreciation | $286.78 | $270.07 | $220.88 | $92.36 |
| Business acquisitions & disposals | -$34.39 | -$1036.61 | -$83.07 | |
| Stock-based compensation | $73.21 | $70.95 | $68.48 | $21.95 |
| Total cash flows from operations | $413.33 | $574.35 | $297.29 | $178.47 |
| Investing activities | ||||
| Capital expenditures | -$314.33 | -$146.34 | -$140.63 | -$137.12 |
| Investments | -$2.05 | -$4.48 | ||
| Total cash flows from investing | -$320.08 | -$172.96 | -$1179.29 | -$223.98 |
| Financing activities | ||||
| Dividends paid | -$34.51 | -$20.32 | ||
| Sale and purchase of stock | $17.86 | $492.36 | $11.84 | $7.08 |
| Net borrowings | $902.87 | -$925.65 | $1192.82 | $9.41 |
| Total cash flows from financing | $862.95 | $675.73 | $1173.63 | $4.88 |
| Effect of exchange rate | $34.28 | $21.72 | -$3.45 | -$1.54 |
| Change in cash and equivalents | $990.48 | $1098.85 | $288.17 | -$42.17 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.96 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |